Department of Pediatrics, All India Institute of Medical Sciences, Jodhpur, India.
Department of Pediatrics, All India Institute of Medical Sciences, Jodhpur, India
BMJ Case Rep. 2021 Mar 10;14(3):e240759. doi: 10.1136/bcr-2020-240759.
Brucellosis is a common zoonotic disease worldwide. It has protean clinical manifestation and sometimes may has a life-threatening complication. A 4-year-old boy presented with a history of fever, myalgia and appetite loss for 3 weeks. On examination, he had hepatosplenomegaly. The initial working diagnosis was an infection, autoimmune disease and malignancy. Investigations showed positive serology, and he was started on rifampicin and cotrimoxazole. He was further investigated because of persistent fever, which revealed evidence of haemophagocytic lymphohistiocytosis (HLH). He continued treatment for brucellosis, except rifampicin which was replaced with doxycyclin due to a worsening liver function. The child showed complete clinical and biochemical improvement after 6 weeks of therapy. HLH is a life-threatening condition and should be suspected in children with brucellosis, who did not respond to appropriate antibiotics treatment. Secondary HLH does not always require specific therapy; it may improve with adequate treatment of the underlying condition.
布鲁氏菌病是一种常见的人畜共患疾病,在全球范围内流行。它的临床表现多样,有时可能会出现危及生命的并发症。一名 4 岁男孩因发热、肌肉痛和食欲减退 3 周来就诊。体格检查发现肝脾肿大。初步临床诊断为感染、自身免疫性疾病和恶性肿瘤。检查发现血清学阳性,给予利福平联合复方磺胺甲噁唑治疗。由于持续发热,进一步检查发现噬血细胞性淋巴组织细胞增生症(HLH)。由于肝功能恶化,停用利福平,换用多西环素。经过 6 周的治疗,患儿的临床和生化指标完全恢复正常。HLH 是一种危及生命的疾病,对于布鲁氏菌病治疗无效的患儿,应怀疑 HLH 的可能。继发 HLH 不一定需要特定的治疗,随着基础疾病的适当治疗,病情可能会改善。